2m 2m 2m 2m 2m 2m 2m
COMPASS THERAPTC (CMPX)
NASDAQ
$2.07+$0.006 (+0.29%)
Price as of Jun 23, 2026 7:53 PM EDT- $378.2MMarket Cap
- -17.32%1-Year Change
- BiotechnologyIndustry
COMPASS THERAPTC (CMPX)
$2.07+$0.006 (+0.29%)
CMPX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.06 | ||
Change | +$0.08 (+3.96%) | ||
Open | $2.04 | ||
High | $2.11 | ||
Low | $2.04 | ||
Previous Close | $2.10 | ||
Volume | 3,107,129 | ||
30-Day Average Volume | 4,170,761 | ||
1-Week Change | 2.94% | ||
1-Month Change | 1.45% | ||
1-Year Change | -17.32% | ||
3-Year Change | -35.98% | ||
5-Year Change | -74.88% | ||
Fundamentals | |||
Shares Outstanding | 180.1M | ||
Total Assets | $205.2M | ||
Market Cap | $378.2M | ||
Enterprise Value | $323.0M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$18.3M | ||
Free Cash Flow | -$17.4M | ||
EBIT | -$18.3M | ||
EBITDA | -$18.3M | ||
Net Working Capital | $185.4M | ||
EPS | -$0.10 | ||
Enterprise Value/EBITDA | -18 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -21 | ||
PEG | 1 | ||
Price/Free Cash Flow | -22 | ||
Price/Operating Cash Flow | -22 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue